{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:51:41Z","timestamp":1791669101801,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s12325-012-0061-5","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T21:19:18Z","timestamp":1352236758000},"page":"947-957","source":"Crossref","is-referenced-by-count":47,"title":["Pregabalin for Alcohol Dependence: A Critical Review of the Literature"],"prefix":"10.1007","volume":"29","author":[{"given":"Riccardo","family":"Guglielmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Janiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,5]]},"reference":[{"key":"61_CR1","first-page":"13","volume":"22","author":"J. Littleton","year":"1998","unstructured":"Littleton J. Neurochemical mechanisms underlying alcohol withdrawal. Alcohol Health Res World. 1998;22:13\u201324.","journal-title":"Alcohol Health Res World"},{"key":"61_CR2","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","volume":"361","author":"B.A. Johnson","year":"2003","unstructured":"Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003;361:1677\u20131685.","journal-title":"Lancet"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1530-0277.1997.tb03733.x","volume":"21","author":"T.I. Mueller","year":"1997","unstructured":"Mueller TI, Stout RL, Rudden S, et al. A doubleblind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res. 1997;21:86\u201392.","journal-title":"Alcohol Clin Exp Res"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hup.833","volume":"22","author":"G. Martinotti","year":"2007","unstructured":"Martinotti G, Di Nicola M, Romanelli R, et al. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Hum Psychopharmacol. 2007;22:149\u2013156.","journal-title":"Hum Psychopharmacol"},{"key":"61_CR5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4088\/JCP.v68n1108","volume":"68","author":"F.A. Furieri","year":"2007","unstructured":"Furieri FA, Nakamura-Palacios EM. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2007;68:1691\u20131700.","journal-title":"J Clin Psychiatry"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J069v21n02_05","volume":"21","author":"L.P. Longo","year":"2002","unstructured":"Longo LP, Campbell T, Hubatch S. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. J Addict Dis. 2002;21:55\u201364.","journal-title":"J Addict Dis"},{"key":"61_CR7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1517\/13543784.2012.703179","volume":"21","author":"G. Martinotti","year":"2012","unstructured":"Martinotti G. Pregabalin in clinical psychiatry and addiction: pros and cons. Expert Opin Investig Drugs. 2012;21:1243\u20131245.","journal-title":"Expert Opin Investig Drugs"},{"key":"61_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","volume":"73","author":"C.P. Taylor","year":"2007","unstructured":"Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007;73:137\u2013150.","journal-title":"Epilepsy Res"},{"key":"61_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03190385","volume":"26","author":"M.R. Feng","year":"2001","unstructured":"Feng MR, Turluck D, Burleigh J, et al. Brain microdialysis and PK\/PD correlation of pregabalin in rats. Eur J Drug Metab Pharmacokinet. 2001;26:123\u2013128.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"61_CR10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1059-1311(02)00295-9","volume":"12","author":"L.D. Errante","year":"2003","unstructured":"Errante LD, Petroff OA. Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure. 2003;12:300\u2013306.","journal-title":"Seizure"},{"key":"61_CR11","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/jpet.104.082255","volume":"313","author":"T.Z. Su","year":"2005","unstructured":"Su TZ, Feng MR, Weber ML. Mediation of highly concentrative uptake of pregabalin by L-type amino acid transport in Chinese hamster ovary and Caco-2 cells. J Pharmacol Exp Ther. 2005;313:1406\u20131415.","journal-title":"J Pharmacol Exp Ther"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/jm049762l","volume":"48","author":"T.R. Belliotti","year":"2005","unstructured":"Belliotti TR, Capiris T, Ekhato IV, et al. Structureactivity relationships of pregabalin and analogues that target the alpha(2)-delta protein. J Med Chem. 2005;48:2294\u20132307.","journal-title":"J Med Chem"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/abio.1997.2447","volume":"255","author":"J.P. Brown","year":"1998","unstructured":"Brown JP, Dissanayake VU, Briggs AR, Milic MR, Gee NS. Isolation of the [3H]gabapentin-binding protein\/alpha 2 delta Ca2+ channel subunit from porcine brain: development of a radioligand binding assay for alpha 2 delta subunits using [3H] leucine. Anal Biochem. 1998;255:236\u2013243.","journal-title":"Anal Biochem"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1460-9568.2004.03625.x","volume":"20","author":"M.O. Cunningham","year":"2004","unstructured":"Cunningham MO, Woodhall GL, Thompson SE, Dooley DJ, Jones RS. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci. 2004;20:1566\u20131576.","journal-title":"Eur J Neurosci"},{"key":"61_CR15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/0091270009352087","volume":"50","author":"H.N. Bockbrader","year":"2010","unstructured":"Bockbrader HN, Radulovic LL, Posvar EL, et al. Clinical pharmacokinetics of pregabalin in healthy volunteers. J Clin Pharmacol. 2010;50:941\u2013950.","journal-title":"J Clin Pharmacol"},{"key":"61_CR16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","volume":"49","author":"H.N. Bockbrader","year":"2010","unstructured":"Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49:661\u2013669.","journal-title":"Clin Pharmacokinet"},{"key":"61_CR17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s12325-008-0066-2","volume":"25","author":"G. Martinotti","year":"2008","unstructured":"Martinotti G, Di Nicola M, Tedeschi D, Mazza M, Janiri L, Bria P. Efficacy and safety of pregabalin in alcohol dependence. Adv Ther. 2008;25:608\u2013618.","journal-title":"Adv Ther"},{"key":"61_CR18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1177\/0269881109102623","volume":"24","author":"G. Martinotti","year":"2010","unstructured":"Martinotti G, Di Nicola M, Tedeschi D, et al. Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. J Psychopharmacol. 2010;24:1367\u20131374.","journal-title":"J Psychopharmacol"},{"key":"61_CR19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1360-0443.2009.02792.x","volume":"105","author":"G. Martinotti","year":"2010","unstructured":"Martinotti G, di Nicola M, Frustaci A, et al. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Addiction. 2010;105:288\u2013299.","journal-title":"Addiction"},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/hup.1098","volume":"25","author":"M. Nicola Di","year":"2010","unstructured":"Di Nicola M, Martinotti G, Tedeschi D, et al. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Hum Psychopharmacol. 2010;25:268\u2013275.","journal-title":"Hum Psychopharmacol"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/alcalc\/agr153","volume":"47","author":"A. F\u00f6rg","year":"2012","unstructured":"F\u00f6rg A, Hein J, Volkmar K, et al. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebocontrolled trial. Alcohol Alcohol. 2012;47:149\u2013155.","journal-title":"Alcohol Alcohol"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","volume":"60","author":"J.A. French","year":"2003","unstructured":"French JA, Kugler AR, Robbins JL, Knapp LE, Garofalo EA. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology. 2003;60:1631\u20131637.","journal-title":"Neurology"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuropharm.2008.09.013","volume":"56","author":"C.J. Siok","year":"2009","unstructured":"Siok CJ, Taylor CP, Haj\u00f3s M. Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation. Neuropharmacology. 2009;56:379\u2013385.","journal-title":"Neuropharmacology"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/npp.2011.32","volume":"36","author":"R.L. Aupperle","year":"2011","unstructured":"Aupperle RL, Ravindran L, Tankersley D, et al. Pregabalin influences insula and amygdala activation during anticipation of emotional images. Neuropsychopharmacology. 2011;36:1466\u20131477.","journal-title":"Neuropsychopharmacology"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/mol.112.077636","volume":"82","author":"M.M. Valente","year":"2012","unstructured":"Valente MM, Bortolotto V, Cuccurazzu B, et al. \u03b12\u03b4 Ligands Act as Positive Modulators of Adult Hippocampal Neurogenesis and Prevent Depression-Like Behavior Induced by Chronic Restraint Stress. Mol Pharmacol. 2012;82:271\u2013280.","journal-title":"Mol Pharmacol"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00228-010-0853-y","volume":"66","author":"S. Schwan","year":"2010","unstructured":"Schwan S, Sundstr\u00f6m A, Stjernberg E, Hallberg E, Hallberg P. A signal for an abuse liability for pregabalin\u2014results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Clin Pharmacol. 2010;66:947\u2013953.","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-012-0061-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-012-0061-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-012-0061-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:56:03Z","timestamp":1559447763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-012-0061-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s12325-012-0061-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}